Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.
about
Mast cells in meningiomas and brain inflammationGlioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and RadioresistanceMolecular biology of gliomas: present and future challengesNADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiformeKCN1, a novel synthetic sulfonamide anticancer agent: in vitro and in vivo anti-pancreatic cancer activities and preclinical pharmacologyParametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signalingWhy is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxiaHypoxia potentiates glioma-mediated immunosuppressionImaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice.Molecular targeting of glioblastoma: Drug discovery and therapiesPotential therapeutic implications of cancer stem cells in glioblastomaHypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheresHypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.In vitro modeling of the neurovascular environment by coculturing adult human brain endothelial cells with human neural stem cellsThe hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells.Anticancer mechanism of apigenin and the implications of GLUT-1 expression in head and neck cancers.TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cellsDifferential glioma-associated tumor antigen expression profiles of human glioma cells grown in hypoxia.Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor.The Bmi-1/NF-κB/VEGF story: another hint for proteasome involvement in glioma angiogenesis?The prospective application of a hypoxic radiosensitizer, doranidazole to rat intracranial glioblastoma with blood brain barrier disruption.The expression of hypoxia-inducible factor-1 in primary brain tumors.Combined efficacy of cediranib and quinacrine in glioma is enhanced by hypoxia and causally linked to autophagic vacuole accumulation.Monitoring oxygen levels in orthotopic human glioma xenograft following carbogen inhalation and chemotherapy by implantable resonator-based oximetry.Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone).Intraoperative visualization of cerebral oxygenation using hyperspectral image data: a two-dimensional mapping method.Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis.Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behaviorγ₁34.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia.Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastropheA preliminary quantitative proteomic analysis of glioblastoma pseudoprogressionRepeated assessment of orthotopic glioma pO(2) by multi-site EPR oximetry: a technique with the potential to guide therapeutic optimization by repeated measurements of oxygenZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres.Hyperbaric oxygen promotes malignant glioma cell growth and inhibits cell apoptosis.Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasionPerioperative cerebral ischemia promote infiltrative recurrence in glioblastoma.Hypoxia Moderates γ(1)34.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary Cultures.Increased age of transformed mouse neural progenitor/stem cells recapitulates age-dependent clinical features of human glioma malignancy.Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses.
P2860
Q21146660-91B0CA8B-B0C4-467F-9E70-6422DF896EB3Q26765869-B5FECB27-8DC6-4739-B0C3-3A469451D2DBQ27001295-4A817749-64BD-4558-B899-17C4F52378CCQ28477083-4BDDDBFE-6F28-4F29-A1A2-78041DFA938BQ28483753-CDFB3B30-EE80-4C73-B130-1007B9906578Q33549622-87F0D29F-7781-4A34-AFAF-7EA4BF33906AQ33789920-E0450392-F4F9-45FE-8DD0-0F2D1C8647CCQ33798508-06281BEE-2D1D-4694-AD8D-679113E4F47EQ33809268-E61331CC-3808-4628-9DFA-22BAC4BF4338Q33862844-841D5BE9-0C5E-4C14-A03D-00EAB2DCC019Q33911283-5EA2F3CC-6627-451C-896B-7385CEDF6471Q33965491-C71A9057-3765-4B2D-85FF-7AA68011E008Q34087018-0E413CD3-00F5-4B07-897E-88817C1304B5Q34107629-1DE86F26-E084-4164-9A79-30C35C06331CQ34133797-B75B3DD9-5CBB-4D8E-8CDB-AB1841BAD7BEQ34285178-83E5ADC6-0F0A-4EE8-9586-99D05DBA54E9Q34366965-B9D9B728-BF3E-449F-A93F-198ED6D39BCCQ34407155-9D765CE5-0D64-4451-A4B3-6DED12566312Q34407938-F79E4601-3C44-4471-BC95-E95884607329Q34480501-D995BE02-5A12-4FEE-BC45-C7376779144AQ34620966-8793F00D-5D71-49A3-A949-C5C25B11E9F1Q34621903-97857174-0818-4D0E-862C-81E4859AB23EQ34646194-CC010414-3952-4EFC-9F57-07C2B5FB1F8CQ34662536-E76FCCFD-288B-4C51-88D8-745FE26A7738Q35039916-B30CA668-A873-4B4E-9D1F-BAAFE891D35EQ35116540-9FB84630-7E6B-4E91-A5C9-2CFCC013F4B7Q35149691-AB465E42-011C-4A54-87A8-CFFF02528EBAQ35213377-2D1ADA82-FB54-40CD-9271-71529E41AA22Q35228388-58B9CCDA-A163-4CAF-9715-4AAC36125D04Q35251719-BF005963-4D74-41F4-80F5-63550C53D7ADQ35273402-6315F740-2782-4E93-96EF-00913989B0ECQ35368468-EFC08C6E-4B9A-4C29-8B55-00A05A275331Q35645306-EEDB8070-3B5C-419E-9AA7-CE84C6693E37Q35752332-9BC422F5-440E-473B-8F25-604A62B372CBQ35803805-CF4E8110-51B0-4D5D-81DC-49B360BFF645Q35914515-485E1EDE-E46F-4FA2-91B1-A1DA18FC5D30Q35987408-68BC2EF1-C26E-4701-B5FB-5B298F23697DQ36061803-A34CB75D-26BD-494C-AD3C-210A58BA262CQ36418417-1C4C0F70-95E4-443C-B600-97C7A8BAA071Q36493813-DC5992A0-6E5C-4F04-81FD-A0FADF52C96D
P2860
Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Brain tumor hypoxia: tumorigen ...... , and as a therapeutic target.
@en
Brain tumor hypoxia: tumorigen ...... , and as a therapeutic target.
@nl
type
label
Brain tumor hypoxia: tumorigen ...... , and as a therapeutic target.
@en
Brain tumor hypoxia: tumorigen ...... , and as a therapeutic target.
@nl
prefLabel
Brain tumor hypoxia: tumorigen ...... , and as a therapeutic target.
@en
Brain tumor hypoxia: tumorigen ...... , and as a therapeutic target.
@nl
P2860
P1476
Brain tumor hypoxia: tumorigen ...... , and as a therapeutic target.
@en
P2093
Randy L Jensen
P2860
P2888
P304
P356
10.1007/S11060-009-9827-2
P577
2009-04-09T00:00:00Z